If there is a delay or no announcement then it will be a bad day to be holding if you are here short term. If you think that there will be a pop then buy the calls and minimize your exposure. I don't think that EU will drive it up as much as FDA would but then again who the heck knows
I think that there will be more pressure on the downside as there are many more PUTS that are in the money than there are in the money CALLS.
Gains will be taken there and you can see it happening today
There are new options expiration dates in Jan that have a negative price pressure on options with Dec 21 and Dec28 expirations. There are expirations every Friday now for the next 3-5 weeks.
I support the good work that PCYC has done on developing a drug to treat CLL. There is no end to the downward trend before the end of the year.
Answer this. If Duggan were to sell a bunch in one stroke, for whatever reason, then that would have an impact on perceived company value. Hence on the investor. You are right that the VP sale should not be considered as a loss of confidence but it nevertheless is viewed negatively. If he had sold them as a string of planned sales like is done most often then it is not so negative. Perception matters so Duggan does not sell.
Good luck all. Hope that PCYC does eveything it can for CLL patients and then some.
So with that line of thinking, you would have no problem if Duggan decided to unload a bunch of his shares.
He has the right. Correct. But sales of this type are a slap in the face of the small investor like me since an execution like this has a negative reading to it. If it does not, then why are insider sales or buys always commented on or an item that is tracked.
I suspect that if your logic is correct then other VPs will unload very soon so perhaps buying PUTS is the way to go until you see that selling has taken place. Going long is risky business under the selling pressure from both the insiders and the shorts and the funds. Down, down, down and I was too stuck on the drug results to do the right thing as the market soured against PCYC.
While he cashed out, I feel like I am holding the magic beans and have no idea if I throw them out the window now that I will see a beanstalk in the morning.
VP Rainer Erdtmann sold 54,000 shares of the stock on the open market in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $107.77, for a total transaction of $5,819,580.00. Following the completion of the sale, the vice president now directly owns 5,497 shares of the company’s stock, valued at approximately $592,412. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Was it Goldman Sachs or another firm that said they would be a buyer below $120 or was it $117. Does not look like there were many heeding their recommendation last week. Let's see about this week and the rest of the month.
it is not so much giving the big players the chance to accumulate now it is more them selling for gains. it was a good year for PCYC and traders are trading, LONGS are suffering in their positions for now, and shorts are wishful that it goes lower. good drug bad investment if you just got in before ASH and still holding.
That's great news. Any weapon against CLL is a good weapon. Unfortunately the patient has to have a certain gene/marker for the CLL to be treatable. What percentage has the gene.
PCYC Investor relations confirmed that it was not a material event and that no 8K was or will be filed. They did not say whether JPM actually made inquiries so the note attributed to JPM by FlyontheWall could have been extended speculation based on a list of open jobs at PCYC. I think as speculated by in the FB Link Article that money managers are doing the end of year rebalance - Fidelity BioTech had a bunch so we will probably see an adjustment in their holding with their next filing.